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Abstract
Background: Insulin-like growth factors (IGF´s) play a crucial role in controlling cancer cell proliferation,
differentiation and apoptosis. Exercise has been postulated as an effective intervention in improving cancer-
related outcomes and survival, although its effects on IGF´s are not well understood. This meta-analysis aimed
to determine the effects of exercise in modulating IGF´s system in breast cancer survivors.
Methods: Databases of PuMed, EMBASE, Cochrane Central Register of Controlled Trials, EMBASE, ClinicalTrials.
gov, SPORTDiscus, LILACS and Scopus were systematically searched up to November 2014. Effect estimates were
calculated through a random-effects model of meta-analysis according to the DerSimonian and Laird method.
Heterogeneity was evaluated with the I2 test. Risk of bias and methodological quality were evaluated using the
PEDro score.
Results: Five randomized controlled trials (n = 235) were included. Most women were post-menopausal. High-
quality and low risk of bias were found (mean PEDro score = 6.2 ± 1). Exercise resulted in significant improvements
on IGF-I, IGF-II, IGFBP-I, IGFBP-3, Insulin and Insulin resistance (P < 0.05). Non-significant differences were found for
Glucose. Aerobic exercise improved IGF-I, IGFBP-3 and Insulin. No evidence of publication bias was detected by
Egger´s test (p = 0.12).
Conclusions: Exercise improved IGF´s in breast cancer survivors. These findings provide novel insight regarding the
molecular effects of exercise on tumoral microenvironment, apoptosis and survival in breast cancer survivors.
Keywords: Breast cancer, Exercise, Insulin-Like Growth Factor Binding Proteins, Tumor Microenvironment
Abbreviations: CI, Confidence interval; ELISA, Enzyme-linked immunosorbent assay; IGF, Insulin-like growth factors;
IGFBP, Insulin-like growth factor binding protein; MD, Mean difference; PEDro, Physiotherapy evidence database;
RCT, Randomized controlled trials; SD, Standard deviation
* Correspondence: robin640@hotmail.com; robinson.ramirez@urosario.edu.co
1Centro de Estudios en Medición de la Actividad Física (CEMA), Escuela de
Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá, DC,
Colombia
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Meneses-Echávez et al. BMC Cancer  (2016) 16:682 
DOI 10.1186/s12885-016-2733-z
Background
Insulin-like growth factors (IGFs) are mitogens involved
in regulating cell proliferation, differentiation, and apop-
tosis [1]. The IGF system includes the single-chain poly-
peptides IGF-I and IGF-II and six binding proteins
(IGFBP-I - IGFBP-6) [2]. The IGFBP proteases may also
be considered as part of the IGF system because they in-
directly regulate the action of IGFs [3]. The IGF family
has been linked to several metabolic and disease states,
including type 1 diabetes and cancer, especially of the
lung, breast, and prostate [3–6]. Both IGF-I and IGF-II
exert mitogenic and antiapoptotic actions and regulate
tumor cell proliferation and differentiation [3], whilst
IGFBP-3 regulates the mitogenic action of IGFs and
inhibits their antiapoptotic effects in breast cancer cells
due to IGF- inhibitory effects on breast cancer cell
growth [7]. In addition, high levels of IGFBP-3 has been
associated with low concentrations of estrogen receptor
(ER) or progesterone receptor and large tumor size,
suggesting a poor prognosis and decreased survival in
cancer patients [8, 9].
Exercise has been proposed as an effective non-
pharmacological intervention to promote psychological
well-being during and following cancer treatment
[10–12]. However, the role of exercise in the modula-
tion of the IGF system remains poorly understood
and experimental evidence has emerged. At the same
time, other researchers have proposed that exercise
can be used as a mechanism to decrease IGF levels
and aid in cancer prevention [13, 14].
Numerous studies have reported higher levels of circu-
lating IGF associated with physical activity, although
many other studies have reported no difference or even
a decrease in IGF levels. For example, in 2009, Irwin et
al. [15] reported significant reductions in IGF-I and
IGFBP-3 in postmenopausal women after a 6-month
walking-based intervention compared to non-exercisers.
However, Sprod et al. [16] found no significant changes
in IGFBP-I and IGFPB-3 after a 12-week intervention of
Tai Chi Chuan in twenty-one breast cancer survivors. A
limited comprehensive summary has been published that
systematically reviews all literature on this topic. In light
of this lack of consensus in the literature, the aim of this
meta-analysis was to determine the effects of exercise in
modulating the IGF system in breast cancer survivors.
Methods
We followed the Preferred Reporting Items for System-
atic Reviews and Meta-Analyses Statement to conduct
this review [17]. No funding was received. The PubMed,
EMBASE, Cochrane Central Register of Controlled Trials,
EMBASE, ClinicalTrials.gov, SPORTDiscus, LILACS and
Scopus databases were systematically searched between
May and November 2014 by three blinded authors (JFME,
JSRV and EGJ) without restrictions on language. The re-
viewers were blinded to both the name of the authors and
the results of the studies. The following search terms were
used: ´breast cancer´ and ´exercise´ or ´physical activity´
and ´insulin´ or ´glucose´ or ´growth factors´ or ´IGF´ or
´IGFBP´. The reference lists from retrieved articles were
checked to identify additional titles. The authors also ex-
amined data from previous reviews published by Ballard-
Barbash et al. [18] and Löf and colleagues [19]. Moreover,
two authors (MI and RR-V) searched for other relevant
trials listed in journals that specialized in oncology (e.g.,
BMC Cancer, Breast Cancer Research, Cancer, Cancer Epi-
demiology, Biomarkers & Prevention, Journal of Clinical
Oncology, Journal of Oncology Practice and The Lancet
Oncology). Aiming to provide stronger sensitivity to the
search process, the authors contacted high-profile re-
searchers in this area to ask for other possibly relevant
trials, published or unpublished.
Selection criteria
Two authors (JSR-V and JEC-B) independently checked
all of the retrieved trials against the eligibility criteria
(Table 1). The title and abstract were examined, and full-
text was obtained if ambiguity regarding the eligibility of
the study was noted. A third author arbitrated the consen-
sus for eligibility (EG-J). Attempts were made to contact
authors of trial reports if clarification was necessary.
A cancer survivor was defined as a person who is diag-
nosed with cancer and survives from the time of diagno-
sis through the balance of his or her life [20]. Exercise
interventions were defined as a form of physical activity
that is planned, structured and repetitive and aims to
improve fitness, performance or health [21]. Hence, we
included randomized controlled trials (RCTs) that com-
pared exercise interventions (aerobic, resistance training
and stretching exercises such as Tai Chi Chuan) with a
control group (conventional care) in women with breast
cancer and that measured the following biomarkers:
Table 1 Inclusion criteria considered in the systematic review
Design
• Randomized controlled trial
Participants
• Women with breast cancer, without restriction to a particular stage
of diagnosis or treatment
Intervention
• Exercise training (i.e., aerobic, resistance training, stretching exercises
and Tai Chi Chuan).
Outcome measures
• Insulin-like growth factor -1 (IGF-1)
• Insulin-like growth factor -2 (IGF-2)
• Insulin-like growth factor-binding protein -1 (IGFBP-1)
• Insulin-like growth factor-binding protein -3 (IGFBP-3)
• Insulin
• Insulin Resistance
• Glucose
Comparisons
• Exercise training versus conventional care
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insulin-like growth factors (IGF-I and IGF-II), insulin-like
growth factor-binding protein (IGFBP-I and IGFBP-3),
and insulin serum levels as well as insulin resistance and
glucose. This set of biomarkers was selected because they
play a vital role in the tumoral microenvironment and can-
cer prognosis [22, 23]. Finally, we excluded trials where ex-
ercise was combined with pharmacological interventions.
Methodological quality assessment
The methodological quality of the studies including their
risk of bias was assessed using the Physiotherapy
Evidence Database (PEDro) scale [24]. The PEDro scale
scores the methodological quality of randomized trials
and has a maximum possible score of 10. Scores were
based on all information available from both the pub-
lished version and from communication with the au-
thors. A score of 5 of 10 was set as the minimum score
for inclusion in the review. The score for each included
study was determined by two trained authors (JFM-E
and MI). Disagreements were solved by consensus or
by a third reviewer (JEC-B). We calculated the inter-
observer agreement using the Kappa (k) statistic [25];
the agreement rate between authors was k = 0.91 for
methodological quality assessment.
Data extraction and analysis
Relevant data were extracted independently by two re-
viewers (JFM-E and RR-V) using a standard form and a
third author (JEC-B) mediated in cases of disagreement.
The reviewers extracted information about the methods
(i.e., design, breast cancer staging, participants and inter-
ventions) and the outcome data for the experimental
and control groups. High agreement was observed be-
tween reviewers (k = 0.89).
Changes in the Insulin-Like Growth Factors were
reported as differences between arithmetic means pre
and post exercise interventions. Statistical heterogeneity
was evaluated using the I2 statistic (I2 = [(Q - df ) / Q] X
100 %, where Q is the chi-square statistic and df is its de-
grees of freedom), which was defined according to the fol-
lowing categories [26]: negligible heterogeneity, 0 % – 40 %;
moderate heterogeneity, 30 % – 60 %; substantial hetero-
geneity, 50 % – 90 %; and considerable heterogeneity,
75 % – 100 %. Other possible sources of heterogeneity
were evaluated via subgroup analysis and a cumulative
meta-analysis model if necessary. We conducted a
random-effects model of the meta-analysis when sub-
stantial heterogeneity (I2 > 50 %) was present. Continu-
ous outcomes were reported as the Standardized Mean
Difference (SMD) with the 95 % confidence interval
(95 % CI), with statistical significance set at a P < 0.05.
All analyses were weighted by the inverse variance. Pub-
lication bias was examined using Egger´s test (P < 0.05)
and the funnel plot based on the number of studies in-
cluded (i.e. if more than 10 trials were included). Based
on data availability, we conducted subgroup analysis to
explore the particular effects of the modes of exercise
separately. All analyses were conducted by JFM-E using
Stata (Version 12.0; Stata Corp, College Station, TX).
Results
Characteristics of the studies included
A total of five randomized controlled trials (n = 235) were
included [15, 16, 27–29]. Figure 1 presents the Additional
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Fig. 1 Flowdiagram for search strategy methods. Flowdiagram is performed according to Additional file 1 Statement
Meneses-Echávez et al. BMC Cancer  (2016) 16:682 Page 3 of 10
file 1 flow diagram. All groups were similar at baseline
with 113 women allocated to the experimental groups and
122 women allocated to the control groups. The average
publication date was 2008 ± 3.5 years. An enzyme-linked
immunosorbent assay (ELISA) was used by all studies
included.
Methodological quality and risk of bias assessment
We found a high-quality and low risk of bias (mean
PEDro score = 6.2 ± 1) across studies. No study performed
blinding of participants or therapists and three trials
(60 %) blinded their assessors for the analyses (Table 2).
Characteristics of the participants
Most women were postmenopausal, with an average age
of 48 ± 3.2 years (range 48-59 years), and were classified
with tumor stages I-IIIA after anti-cancer treatment.
Chemotherapy was the most common treatment (n = 176)
followed by radiotherapy (n = 124), and 57 participants re-
ceived hormonal therapy, with the majority of participants
receiving tamoxifen. Finally, 133 women received mastec-
tomy and 104 were treated through lumpectomy.
Characteristics of the exercise interventions
The interventions had a mean length of 22.2 ± 13.5 weeks
with an average of 2.8 ± 0.5 sessions per week. The
longest exercise intervention length was 12 months re-
ported by Schmitz et al. [29]. The mean session duration
was 73 ± 9.6 min. Exercise interventions included aer-
obic exercise (i.e., walking and stationary cycling) in 2
trials (40 %) [15, 26], resistance training (i.e., strength
training) was implemented by Schmitz et al. [29] and
Tai Chi Chuan exercises were implemented in two trials
[16, 27]. The training intensity varied considerably
among studies, ranging from 50 % to 90 % of the max-
imum heart rate. The adherence rate was 83.7 ± 8.7 %.
No major adverse effects were reported. Finally, all
studies reported pre-exercise screening before high
intensity physical training. Table 3 summarizes the
characteristics of the included studies.
Effects of exercise on insulin-like growth factors (IGFs)
and their binding proteins (IGFBP-I and IGFBP-3)
Changes in the circulating levels of IGF-I after exercise
training were evaluated in five studies [15, 16, 26–29].
The pooled SMD was -0.74 (95 % CI -1.14 to -0.34;
I2 = 52.8 %), indicating a moderate reduction in IGF-I
following exercise (Fig. 2).
Similar improvements were obtained for IGF-II
(SMD = -0.96, 95 % CI -1.33 to -0.59; I2 = 91.4 %)
[26, 28] (Fig. 3), which was measured in two studies
[26, 28]. These estimates were obtained using a
random-effects model. A meta-regression analysis to
explore dose–response relationships was not conducted
due to the limited number of studies included.
Based on data from four articles [15, 26–28], the
pooled estimates revealed that exercise improved the
serum levels of Insulin-like growth factor-binding
protein-I (IGFBP-I) (SMD = 0.51, 95 % CI 0.20 to 0.82;
I2 = 62 %) (Fig. 4).
All of the studies included [15, 16, 26–28] evaluated
the serum concentrations of IGFBP-3 and demon-
strated that exercise training significantly increased
the serum levels of this biomarker in women with
breast cancer (SMD = 0.54, 95 % CI 0.27 – 0.80; I2 =
84.2 %) (Fig. 5).
In addition, exercise interventions resulted in significant
differences in the levels of insulin (SMD= 0.94, 95 % CI
0.70 – 1.19; I2 = 93.8 %) (Fig. 6) and insulin resistance
(SMD= -0.35, 95 % CI -0.70 to -0.009; I2 = 0 %). Non-
significant differences were obtained for glucose levels
(SMD= -0.16, 95 % CI -0.43 to 0.10; I2 = 0 %).
Subgroup analysis by mode of exercise
Regarding the subgroup analyses, aerobic exercise im-
proved the serum concentrations of IGF-I, IGFBP-3 and
Table 2 PEDro Scale scores for the included trials (n = 5)
Study Random
allocation
Concealed
allocation
Groups
similar at
baseline
Participant
blinding
Therapist
blinding
Assessor
Blinding
<15 %
dropouts
Intention
to treat
analysis
Between-group
difference
reported
Point estimate
and variability
reported
Total
(0 to 10)
Fairey et al. [26]
(2003)
Y N Y N N Y Y Y Y Y 7
Irwin et al. [14]
(2009)
Y N Y N N Y Y Y Y Y 7
Janelsins et al. [27]
(2011)
Y Y Y N N N N N Y Y 5
Schmitz et al. [28]
(2005)
Y N Y N N Y Y N Y Y 6
Sprod et al. [15]
(2012)
Y Y Y N N N N Y Y Y 6
Compliance rate 100 % 40 % 100 % 0 % 0 % 60 % 60 % 60 % 100 % 100 % 100 %
N No, Y Yes, PEDro Physiotherapy Evidence Database
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insulin. Aerobic exercise analysis for IGFBP-I was not
possible because only Fairey et al. [26] evaluated this
marker. Tai-Chi training resulted in significant benefits
for insulin levels. Tai-Chi also improved the serum con-
centrations of IGF-I, IGFBP-I and IGFBP-3, although
these effects did not reach significance. Resistance train-
ing analysis was not conducted because only Schmitz et
al. [29] evaluated this mode of exercise. Subgroup ana-
lysis for IGF-II was not possible because the two studies
that measured this marker implemented different exer-
cise modes [26, 28]. Figure 7 displays the subgroup ana-
lysis according to mode of exercise for IGFBP-3. Table 4
describes the effect estimates for the subgroup analyses
undertaken in the meta-analysis.
Table 3 Characteristics of the five randomized controlled trials included in the systematic review and meta-analysis
Study ID Design Stage of
Disease
Participants Interventions Outcome measures
Fairey
et al. [26]
(2003)
RCT Breast
Cancer
Stage I –IIIB
Characteristics of cancer treatment =
Women who had completed surgery,
radiotherapy, and/or chemotherapy.
N = 53
Female = 53
Exp (n = 25)
Age (yr) = 59 (5)
Con (n = 28)
Age (yr) = 58 (6)
Exp = Aerobic exercise.
Length = 15 weeks.
Duration = Exercise began at 15 min
for weeks 1–3, and then systematically
increased by 5 min every 3 weeks
thereafter to 35 min for weeks 13–15.
Frequency = 3 ses/wk.
Intensity = 70 %-75 %.
Con = Conventional care.
Godin Leisure-Time Exercise
Questionnaire, fasting blood.
Irwin
et al. [14]
(2009)
RCT Breast
Cancer Stage
0-IIIA
Characteristics of cancer treatment =
Women who had completed surgery,
radiotherapy, and/or chemotherapy.
N = 68
Female = 68
Exp (n = 36)
Age (yr) = 56.4 (9.5)
Con (n = 32)
Age (yr) = 55.6 (7.7)
Exp = A combined supervised training
program at a local health club and a
home aerobic training program.
Length = 24 weeks.
Duration = 129 min/wk.
Frequency = Participants exercised three
times per week and were instructed to
exercise two days/ week on their own,
either at the health club or home.
Intensity = Moderate-intensity.
Con = Conventional care.
Duration = 45 min/wk.
Ainsworth’s Compendium
of Physical Activities and
fasting blood.
Janelsins
et al. [27]
(2011)
RCT Breast
Cancer
Stage 0-IIIb
Characteristics of cancer
treatment = Surgery with axillary
lymphadenectomy and both
post-surgery radiotherapy
and chemotherapy.
Female = 19
Exp (n = 9)
Age (yr) = 54.33 (10.64)
Con (n = 10)
Age (yr) = 52.70 (6.67)
Exp = Tai Chi Chuan (TCC).
Length = 12 weeks.
Duration = 60 min/session
Frequency = 3 session/week.
Intensity = Moderate or vigorous.
Con = Psychosocial therapy
Bioelectrical impedance tests,
Fasting blood.
Schmitz
et al. [28]
(2005)
RCT Breast
Cancer
Stage I-III
Characteristics of cancer treatment =
Radiation treatment, chemotherapy,
axillary dissection, and hormonal
therapy
N = 85
Female = 85
Exp (n = 33)
Age (yr) = 53.3 (8.7)
Con (n = 36)
Age (yr) = 52.8 (7.6)
Exp = weight training
Length = 12 month (26 weeks)
Duration = 60 min each session
Frequency = twice-weekly
Intensity =moderate
Con = conventional care 0-6
month weight training 7-12 month
Body weight, height, body fat,
lean mass, body fat %, and waist
circumference, as well as fasting
glucose, insulin, insulin resistance,
insulin-like growth factor-I (IGF-I),
IGF-II, and IGF-binding protein-1,
IGFBP-2, and IGFBP-3.
Sprod
et al. [16]
(2012)
RCT Breast
Cancer
Stage 0–IIIb
Characteristics of cancer treatment =
Surgery (lymphadenectomy and
mastectomy) post-surgery
radiotherapy and chemotherapy.
N = 19
Female = 19
Exp (n = 9)
Age (yr) = 54.33 (3.55)
Con (n = 10)
Age (yr) = 52.70 (2.11)
Exp = Tai chi chuan exercise.
Length = 12 weeks.
Duration = 60 min/ses.
Frequency = 3 ses/wk.
Intensity = low to moderate
Con = Standard support therapy
control (SST)
Cytokine levels and
fasting blood.
RCT Randomized Controlled Trial, Exp Experimental Group, Con Control Group
Data are presented as mean (SD)
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Publication bias
No evidence of publication bias was detected by Egger´s
test (P = 0.12); a funnel plot was not built due to the lim-
ited number of studies included in the pooled analysis.
Discussion
The most remarkable finding from this meta-analysis
was that exercise training improved the serum levels of
IGF-I, IGF-II, IGFBP-I and IGFBP-3 in breast cancer
survivors after successful anticancer treatment. Similar
conclusions have been reported in previous experimental
studies [15, 26, 28]. Moreover, it is important to high-
light that this is the first meta-analysis that has summa-
rized the effectiveness of exercise training in modulating
the IGF system in breast cancer survivors because a pre-
vious systematic review regarding exercise and blood
biomarkers in breast cancer survivors was published by
Löf and colleagues [19], but the authors did not under-
take data synthesis analysis.
The mitogenic and antiapoptotic effects of IGF-1 are
related to a poorer prognosis in breast cancer [30] and
increased all-cause mortality [31]. The type of exercise
did not appear to affect any putative association; how-
ever, it is probable that different exercise modalities
cause different responses in IGF-1. Our pooled analysis
demonstrated that exercise reduced IGF-I concentra-
tions in women with breast cancer after successful treat-
ment. These findings are consistent with those by some
studies included in our meta-analysis, such as the trial
published by Fairey et al. [26], in which a 15-week aerobic
exercise intervention resulted in significant decreases in
IGF-I levels (10.9 %) in fifty-three postmenopausal breast
cancer survivors. Data from a Yale study [15] also confirm
our findings; in this study, the authors found an 8.9 % sig-
nificant reduction in IGF -I in an experimental group
composed of 38 breast cancer survivors that completed
150 min/wk of moderate intensity aerobic exercise during
5 weeks compared to a control intervention (i.e., instruc-
tions for patients to maintain their current physical activ-
ity level). Another consideration in assessing studies using
an exercise intervention is the timing of blood sampling in
relation to exercise. Most studies that have demonstrated
a post-exercise increase in IGF-1 found an immediate
post-exercise spike followed by a gradual return to base-
line or lower than baseline IGF -1 levels over the next
30 min to several hours [13].
It has been demonstrated that IGFBP-3 restricts IGF-1
availability and biological activity [32] and thus, low
levels of IGFBP-3 have been associated with an increased
risk of breast cancer [33] and a poorer prognosis and
Fig. 3 Meta-analysis for the effect estimate of exercise on circulating levels of IGF-II. Standardized Mean Difference (SMD) was calculated for the
Random effects model of meta-analysis
Fig. 2 Meta-analysis for the effect estimate of exercise on circulating levels of IGF-I. Standardized Mean Difference (SMD) was calculated for the
Random effects model of meta-analysis
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have been postulated as predictors of distant recurrence
of breast carcinoma in postmenopausal women [1, 34].
We found that exercise training increased IGFBP-3
serum levels in breast cancer survivors, although high
statistical heterogeneity was observed in the overall ef-
fect estimate (I2 = 84.2 %). We obtained similar results
for the aerobic exercise subgroup analysis. These find-
ings are consistent with those published by Fairey et al.
[26] and Irwin et al. [15] from the Yale study described
above. In addition, when adjusted by exercise mode in
the subgroup analysis, we found that Tai Chi was an ef-
fective intervention in increasing IGFBP-3 serum levels
in breast cancer survivors, although statistical signifi-
cance was not reached. Similar results were published by
Janelsins et al. [28] in a randomized controlled trial in
19 breast cancer survivors, where a 12-week exercise
intervention of Tai Chi increased IGFBP-3 serum levels
compared to non -exercise. Conversely, non-significant
changes in IGFBP-3 were observed by Sprod et al. [16]
in a more recent study with a similar intervention using
Tai Chi. Interestingly, the authors reported an associ-
ation between changes in IGFBP-3 and physical func-
tioning, suggesting a link between changes in IGF
binding proteins and some domains of quality of life in
breast cancer survivors, although these associations war-
rant additional research. However, several studies that
have reported a change in IGFBP-3 following an acute
exercise challenge usually found a pattern similar to that
found for total IGF-1 [13].
Regarding the secondary outcomes of this meta-
analysis, our analyses showed that exercise produces sig-
nificant increases in insulin and significant decreases in
the insulin resistance of breast cancer survivors; reduc-
tions in the glucose levels did not reach statistical sig-
nificance. Subgroup analysis by mode of exercise was
limited for insulin and insulin resistance due to the
number of studies included. Similar to our results, Sprod
et al. [16] reported slight increases in insulin levels after
a Tai Chi intervention. Nonetheless, other studies have
reported mixed findings. Schmitz et al. [29] found no
changes in insulin or glucose after weight training exer-
cise in 85 breast cancer survivors; Ligibel et al. [35]
detected significant reductions in insulin levels after a
twice-weekly resistance training intervention for 16 weeks
in breast cancer survivors. Lastly, Irwin et al. [15] stated
that the lack of changes in insulin and glucose levels can
be affected by weight status at baseline (i.e., obese breast
cancer survivors have higher insulin levels than
Fig. 4 Meta-analysis for the effect estimate of exercise on circulating levels of IGFBP-I. Standardized Mean Difference (SMD) was calculated for the
Random effects model of meta-analysis
Fig. 5 Meta-analysis for the effect estimate of exercise on circulating levels of IGFBP-3. Standardized Mean Difference (SMD) was calculated for
the Random effects model of meta-analysis
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participants with normal or lower weight), suggesting
that heavier participants can benefit more from exercise
compared to leaner participants with respect to changes
in glycemic control.
In this sense, several biologically plausible mechanisms
could explain the effects of exercise in modulating the
IGF and IGFBP systems. It is widely known that exercise
has the potential to reduce both hepatic and muscle
insulin resistance and to increase glucose availability due
to insulin signaling pathways, improvements in capillary
density leading to a better delivery of muscle glucose,
increases in glucose protein transporters and effects on
mRNA [36]. These conditions decrease the insulin
concentration due to lower concentrations of IGFs via
insulin-mediated changes in IGFBP concentrations
[14]. However, further research is needed to confirm
these mechanisms, especially in breast cancer survivors
during and after anticancer treatment regimens, and
gain insight regarding the benefits that exercise and
multidimensional behavioral change interventions can
provide on cancer treatment related outcomes and
survival, moving from preventive strategies toward pa-
tients facing cancer.
Only one study examined the effects of resistance
training alone, and this method was also beneficial [29].
The effects of resistance exercise have not been ad-
dressed by the American Cancer Society but have been
examined recently in people undergoing cancer treat-
ment [37]. However, the present meta-analysis indicates
that further evidence regarding the effects of resistance
training during and after anticancer treatment. Besides,
to understand the possible mechanisms, more informa-
tion is required regarding the effects of initial chemo-
therapy and radiation therapy on muscle satellite
(progenitor) cells that proliferate in response to resist-
ance exercise [10, 11].
Strengths and limitations
To our knowledge, this is the first meta-analysis that
evaluates the changes on insulin-like growth factors and
their binding proteins after exercise training in breast
cancer survivors. Our results provide novel insight
Fig. 6 Meta-analysis for the effect estimate of exercise on circulating levels of insulin. Standardized Mean Difference (SMD) was calculated for the
Random effects model of meta-analysis
Fig. 7 Meta-analysis for subgroup analysis by mode of exercise. Standardized Mean Difference (SMD) was calculated for the Random effects
model of meta-analysis
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regarding the role of exercise as a non-pharmacological
and non-cytotoxic effective intervention in modulating
the tumoral microenvironment as well as in the manage-
ment of cancer treatment-related side effects (i.e., fatigue,
depression and impairments of quality of life). In addition,
there were numerous methodological limitations that im-
pacted the generalizability of studies, including a lack of
adjustment for confounding factors (e.g., plasma volume,
participant age or body composition) and a lack of consid-
eration of effect modification [13]. Furthermore, our find-
ings have crucial implications on cancer recurrence and
disease free survival rates. In addition, all studies included
exhibited moderate to high methodological quality and
low risk of bias, which is an important issue in terms of
external validity.
Nevertheless, some limitations with regard to our study
exist that are important to state. The overall effects esti-
mates were increased due to different modes of exercise
across the studies included, although such differences
were approached through subgroup analysis according to
the mode of exercise. High statistical heterogeneity levels
were detected for most of the effect estimates, which sug-
gests some caution when interpreting our findings. This
evidence of heterogeneity was counteracted by a random
effects model of analysis and can be explained by differ-
ences in some characteristics of exercise such as intensity,
duration, intervention length, follow up periods and ad-
herence rates across studies. Furthermore, dose–response
relationships were not explored due to the number of
studies included, and further trials might provide specific
details regarding training intensity, duration and length of
exercise interventions in order to strength the consensus
in this field. Finally, considering that all studies involved
women who completed their therapeutic treatments, it is
important that further studies include patients during the
active treatment stages to elucidate the effects of exercise
on IGFs in patients undergoing anti-cancer treatment.
Conclusions
Exercise training is an effective and safe intervention for
the improvement of serum levels of the IGF system and
its binding proteins (IGFBP-I and IGFBP3) as well as for
insulin and glucose control in breast cancer survivors,
suggesting a beneficial role of exercise for the tumoral
microenvironment and breast cancer recurrence and dis-
ease free survival rates in women with breast malignan-
cies. Important components for future research have
been identified that should address many of the limita-
tions found in the reviewed studies, which would ad-
vance this area of research by answering questions on
exercise, IGFs, and health, an area that is growing in
interest and importance. High-quality studies are necessary
to determine an optimal exercise program and to assess
the clinical relevance of the results of available research.
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